Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: a multicentre US study. (avaa uuden ikkunan)

Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A

Lähde‎: Br J Haematol. 2022;197(3):359-66.

Arkistoitu‎: PubMed 35179784

DOI‎: 10.1111/bjh.18081

https://pubmed.ncbi.nlm.nih.gov/35179784/ (avaa uuden ikkunan)

Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. (avaa uuden ikkunan)

Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, Bayik M, Akoglu T.

Lähde‎: Br J Haematol 1998;103(4):1061-3.

Arkistoitu‎: PubMed 9886319

https://www.ncbi.nlm.nih.gov/pubmed/9886319 (avaa uuden ikkunan)

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. (avaa uuden ikkunan)

Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG.

Lähde‎: Ann Intern Med 2007;146(1):25-33.

Arkistoitu‎: PubMed 17200219

https://www.ncbi.nlm.nih.gov/pubmed/17200219 (avaa uuden ikkunan)

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. (avaa uuden ikkunan)

Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG

Lähde‎: Lancet Haematol 2020;7(9):e640-8.

Arkistoitu‎: PubMed 32853584

DOI‎: 10.1016/S2352-3026(20)30227-1

https://www.ncbi.nlm.nih.gov/pubmed/32853584 (avaa uuden ikkunan)

A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. (avaa uuden ikkunan)

Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, Gent M.

Lähde‎: J Pediatr 1993;123(6):989-95.

Arkistoitu‎: PubMed 8229536

https://www.ncbi.nlm.nih.gov/pubmed/8229536 (avaa uuden ikkunan)

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. (avaa uuden ikkunan)

Borst F, Keuning JJ, van Hulsteijn H, Sinnige H, Vreugdenhil G.

Lähde‎: Ann Hematol 2004;83(12):764-8.

Arkistoitu‎: PubMed 15309522

DOI‎: 10.1007/s00277-004-0908-1

https://www.ncbi.nlm.nih.gov/pubmed/15309522 (avaa uuden ikkunan)

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. (avaa uuden ikkunan)

British Committee for Standards in Haematology General Haematology Task Force.

Lähde‎: Br J Haematol 2003;120(4):574-96.

Arkistoitu‎: PubMed 12588344

https://www.ncbi.nlm.nih.gov/pubmed/12588344 (avaa uuden ikkunan)

IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. (avaa uuden ikkunan)

Carcao M, Silva M, David M, Klaassen RJ, Steele M, Price V, Wakefield C, Kim L, Stephens D, Blanchette VS

Lähde‎: Blood Adv 2020;4(7):1492-1500.

Arkistoitu‎: PubMed 32282882

DOI‎: 10.1182/bloodadvances.2019001343

https://www.ncbi.nlm.nih.gov/pubmed/32282882 (avaa uuden ikkunan)

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. (avaa uuden ikkunan)

Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, Wong WS, Cheng G.

Lähde‎: N Engl J Med 2003;349(9):831-6.

Arkistoitu‎: PubMed 12944568

DOI‎: 10.1056/NEJMoa030254

https://www.ncbi.nlm.nih.gov/pubmed/12944568 (avaa uuden ikkunan)

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. (avaa uuden ikkunan)

Ghanima W, Godeau B, Cines DB, Bussel JB.

Lähde‎: Blood 2012;120(5):960-9.

Arkistoitu‎: PubMed 22740443

DOI‎: 10.1182/blood-2011-12-309153

https://www.ncbi.nlm.nih.gov/pubmed/22740443 (avaa uuden ikkunan)

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice. (avaa uuden ikkunan)

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR

Lähde‎: Br J Haematol 2017;178(6):959-70.

Arkistoitu‎: PubMed 28573819

DOI‎: 10.1111/bjh.14788

https://www.ncbi.nlm.nih.gov/pubmed/28573819 (avaa uuden ikkunan)

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. (avaa uuden ikkunan)

Kojouri K, Vesely SK, Terrell DR, George JN.

Lähde‎: Blood 2004;104(9):2623-34.

Arkistoitu‎: PubMed 15217831

DOI‎: 10.1182/blood-2004-03-1168

https://www.ncbi.nlm.nih.gov/pubmed/15217831 (avaa uuden ikkunan)

Romiplostim or standard of care in patients with immune thrombocytopenia. (avaa uuden ikkunan)

Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP.

Lähde‎: N Engl J Med 2010;363(20):1889-99.

Arkistoitu‎: PubMed 21067381

DOI‎: 10.1056/NEJMoa1002625

https://www.ncbi.nlm.nih.gov/pubmed/21067381 (avaa uuden ikkunan)

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. (avaa uuden ikkunan)

Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, Vianelli N, Avvisati G, Rodeghiero F, Amendola A, Baronci C, Carbone C, Quattrin S, Fioritoni G, D'Alfonso G, Mandelli F; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Thrombocytopenia Working Party.

Lähde‎: Blood 2007;109(4):1401-7.

Arkistoitu‎: PubMed 17077333

DOI‎: 10.1182/blood-2005-12-015222

https://www.ncbi.nlm.nih.gov/pubmed/17077333 (avaa uuden ikkunan)

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. (avaa uuden ikkunan)

Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology.

Lähde‎: Blood 2011;117(16):4190-207.

Arkistoitu‎: PubMed 21325604

DOI‎: 10.1182/blood-2010-08-302984

https://www.ncbi.nlm.nih.gov/pubmed/21325604 (avaa uuden ikkunan)

American Society of Hematology 2019 guidelines for immune thrombocytopenia. (avaa uuden ikkunan)

Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kühne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK

Lähde‎: Blood Adv 2019;3(23):3829-66.

Arkistoitu‎: PubMed 31794604

DOI‎: 10.1182/bloodadvances.2019000966

https://www.ncbi.nlm.nih.gov/pubmed/31794604 (avaa uuden ikkunan)

International consensus report on the investigation and management of primary immune thrombocytopenia. (avaa uuden ikkunan)

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ.

Lähde‎: Blood 2010;115(2):168-86.

Arkistoitu‎: PubMed 19846889

DOI‎: 10.1182/blood-2009-06-225565

https://www.ncbi.nlm.nih.gov/pubmed/19846889 (avaa uuden ikkunan)

Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. (avaa uuden ikkunan)

Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB.

Lähde‎: Blood 1997;89(8):2689-700.

Arkistoitu‎: PubMed 9108386

https://www.ncbi.nlm.nih.gov/pubmed/9108386 (avaa uuden ikkunan)